The Benefits of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome
VIR-AGE
The Value of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome: a Randomised Controlled Trial of Mixed Efficacy and Implementation vs. Conventional Rehabilitative Care
1 other identifier
interventional
50
1 country
1
Brief Summary
Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems. For the majority of these patients, a stay in a geriatric medical and rehabilitation centre is necessary, enabling an objective assessment of these disorders and multi-professional care, including physiotherapists, occupational therapists and adapted physical activity teachers, aimed at restoring safe movement and motor independence. However, rehabilitation relies on traditional exercises that are limited, repetitive and sometimes far removed from everyday activities. Technological innovations such as virtual reality (VR) offer opportunities to improve care by creating immersive environments that reproduce real-life situations. VR could thus help to rehabilitate the motor problems associated with MS. The aim of the VIR-AGE project is to study the clinical benefits of VR in the rehabilitation of hospitalised elderly people suffering from PMDS in terms of functional deficits, particularly motor deficits. The study will take place at the Centre gériatrique Champmaillot of the CHU Dijon Bourgogne. A total of 50 patients with SPDM will take part. The total duration of your participation is 5 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedStudy Start
First participant enrolled
July 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
April 21, 2026
April 1, 2026
2.1 years
June 10, 2025
April 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in 'Timed Up and Go' time between initial and final assessment
5 weeks
Study Arms (2)
Experimental: conventional rehabilitation + 3 virtual reality sessions
EXPERIMENTALControl: conventional rehabilitation + 3 additional rehabilitation sessions
ACTIVE COMPARATORInterventions
3 assessment visits (initial (V1), intermediate (V2) and final (V3). A series of motor assessments carried out by the physiotherapist: * Timed Up and Go Test (TUG) * 10 m walk test (TM10) * Functional Reach Test (FRT) * Minimum Motor Test (TMM) * 10 m walk test combined with a verbal task such as naming different animals
Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.
3 virtual reality sessions per week, each lasting 30 minutes.
3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions.
Eligibility Criteria
You may qualify if:
- Person who has given written consent
- Person aged ≥ 65 years;
- With a proven diagnosis of motor maladjustment syndrome;
- Hospitalised in a geriatric care unit;
- Able to understand a simple instruction and answer a closed question;
- Ability to perform the TUG within 7 days of arriving on site
You may not qualify if:
- Person not affiliated to or not benefiting from a social security scheme
- Person subject to a legal protection measure (curatorship, guardianship)
- Person subject to a judicial protection measure
- An adult who is incapable or unable to give consent
- Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
- Anyone with a severe visual and/or hearing impairment
- Any person with a behavioural disorder (agitation, aggressiveness)
- Any person with a severe walking or balance problem that makes motor exercises unsuitable
- Anyone with a pathology, injury, wound or severe deformity to the head or cervical spine
- Any person suffering from severe vertigo, diagnosed at the discretion of the investigating doctor
- Inability to use arm for pointing
- Persons susceptible to migraines
- Non-French speakers
- Anyone with an inter-pupillary distance outside the range of possible helmet adjustments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Dijon Bourgogne
Dijon, 21000, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2025
First Posted
June 18, 2025
Study Start
July 16, 2025
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
April 21, 2026
Record last verified: 2026-04